|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
NZ500590A
(en)
*
|
1997-04-22 |
2001-11-30 |
Cocensys Inc |
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
|
|
EP1032377B1
(en)
|
1997-11-21 |
2010-11-17 |
Purdue Neuroscience Company |
Substituted 2-aminoacetamides and the use thereof
|
|
GB9727523D0
(en)
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Alpha-aminoamide derivatives useful as analgesic agents
|
|
US6281211B1
(en)
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
|
DK1169060T3
(da)
|
1999-04-09 |
2006-01-16 |
Euro Celtique Sa |
Natriumkanalblokkerpræparater og anvendelse deraf
|
|
WO2000073280A1
(en)
*
|
1999-05-28 |
2000-12-07 |
Cheil Jedang Corporation |
Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
AR029489A1
(es)
|
2000-03-10 |
2003-07-02 |
Euro Celtique Sa |
Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
|
|
ATE354568T1
(de)
*
|
2000-08-08 |
2007-03-15 |
Ortho Mcneil Pharm Inc |
Nicht-imidazol aryloxypiperidine als h3 rezeptor liganden
|
|
GB0025208D0
(en)
|
2000-10-13 |
2000-11-29 |
Euro Celtique Sa |
Delayed release pharmaceutical formulations
|
|
ES2305125T3
(es)
*
|
2000-10-26 |
2008-11-01 |
Amgen Inc. |
Agentes anti-inflamatorios.
|
|
US7244853B2
(en)
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
|
EP1392219A4
(en)
|
2001-05-10 |
2007-01-24 |
Cytovia Inc |
SUBSTITUTED N '- (ARYLCARBONYL) -BENZYLIDENE-HYDRAZIDE N' - (ARYLCARBONYL) -BENZHYDRAZIDES AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCERS AND USE THEREOF
|
|
US6831193B2
(en)
|
2001-05-18 |
2004-12-14 |
Abbott Laboratories |
Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptors
|
|
DK1392643T3
(da)
*
|
2001-05-18 |
2006-01-30 |
Abbott Lab |
(1S)-1,2,3,4-tetrahydro-1-naphthalenylbenzamider, der er trisubstituerede ved N, og som inhiberer receptorer indeholdende P2X3 og P2X2/3
|
|
EP1399159A4
(en)
*
|
2001-06-01 |
2007-02-14 |
Cytovia Inc |
4-SUBSTITUTED 1- (ARYLMETHYLIDEN) THIOSEMICARBAZIDE, 4-SUBSTITUTED 1- (ARYLCARBONYL) THIOSEMICARBAZIDE AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCTORS AND THEIR USE
|
|
DK1423168T3
(da)
|
2001-09-03 |
2006-05-15 |
Newron Pharm Spa |
Farmaceutisk præparat omfattende gabapentin eller en analog deraf og et alfa-aminoamid og dets analgetiske anvendelse
|
|
AR036873A1
(es)
|
2001-09-07 |
2004-10-13 |
Euro Celtique Sa |
Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
|
|
AR037233A1
(es)
|
2001-09-07 |
2004-11-03 |
Euro Celtique Sa |
Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
|
|
AR040126A1
(es)
|
2002-05-29 |
2005-03-16 |
Glaxo Group Ltd |
Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento
|
|
US7521062B2
(en)
|
2002-12-27 |
2009-04-21 |
Novartis Vaccines & Diagnostics, Inc. |
Thiosemicarbazones as anti-virals and immunopotentiators
|
|
EP1438956A1
(en)
|
2003-01-16 |
2004-07-21 |
Newron Pharmaceuticals S.p.A. |
Alpha-aminoamide derivatives useful as antimigraine agents
|
|
AU2004207010A1
(en)
*
|
2003-01-30 |
2004-08-12 |
Dynogen Pharmaceuticals, Inc. |
Methods of treating lower urinary tract disorders using sodium channel modulators
|
|
EP1626718A4
(en)
*
|
2003-05-01 |
2010-05-05 |
Panacea Pharmaceuticals Inc |
METHOD FOR THE TREATMENT OF ISCHEMIC ILLNESSES
|
|
EP1802623A1
(en)
*
|
2004-10-12 |
2007-07-04 |
Novo Nordisk A/S |
11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
|
|
US8999289B2
(en)
|
2005-03-22 |
2015-04-07 |
President And Fellows Of Harvard College |
Treatment of protein degradation disorders
|
|
KR20080069189A
(ko)
*
|
2005-11-01 |
2008-07-25 |
트랜스테크 파르마, 인크. |
치환된 아미드의 약학적 사용
|
|
EA200801243A1
(ru)
*
|
2005-11-01 |
2008-10-30 |
Транстек Фарма |
Фармацевтическое применение замещенных амидов
|
|
US8222423B2
(en)
|
2006-02-14 |
2012-07-17 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
|
WO2007095584A2
(en)
|
2006-02-14 |
2007-08-23 |
The President And Fellows Of Harvard College |
Histone Deacetylase Inhibitors
|
|
JP2009530346A
(ja)
*
|
2006-03-21 |
2009-08-27 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
メタボリックシンドロームの治療用のアダマンタン誘導体
|
|
KR20090014347A
(ko)
|
2006-04-07 |
2009-02-10 |
하이 포인트 파마슈티칼스, 엘엘씨 |
11β-히드록시스테로이드 탈수소효소 타입 1 활성 화합물
|
|
US8304451B2
(en)
|
2006-05-03 |
2012-11-06 |
President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
EP2038255A2
(en)
*
|
2006-06-16 |
2009-03-25 |
High Point Pharmaceuticals, LLC |
Pharmaceutical use of substituted piperidine carboxamides
|
|
EP1878721A1
(en)
*
|
2006-07-13 |
2008-01-16 |
Novo Nordisk A/S |
4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
|
WO2008006702A1
(en)
*
|
2006-07-13 |
2008-01-17 |
High Point Pharmaceuticals, Llc. |
11beta-hydroxysteroid dehydrogenase type 1 active compounds
|
|
WO2008101885A1
(en)
*
|
2007-02-23 |
2008-08-28 |
High Point Pharmaceuticals, Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2150526B1
(en)
|
2007-02-23 |
2017-09-20 |
vTv Therapeutics LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2129652A2
(en)
*
|
2007-02-23 |
2009-12-09 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2125704A1
(en)
*
|
2007-02-23 |
2009-12-02 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
WO2008110196A1
(en)
*
|
2007-03-09 |
2008-09-18 |
High Point Pharmaceuticals, Llc |
Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
|
|
US20100056600A1
(en)
*
|
2007-03-28 |
2010-03-04 |
Soren Ebdrup |
11beta-hsd1 active compounds
|
|
CN101677562A
(zh)
*
|
2007-04-11 |
2010-03-24 |
高点制药有限责任公司 |
新化合物
|
|
ES2393230T3
(es)
*
|
2007-04-24 |
2012-12-19 |
High Point Pharmaceuticals, Llc |
Uso farmacéutico de amidas sustituidas
|
|
MX2009013332A
(es)
|
2007-06-08 |
2010-01-25 |
Mannkind Corp |
Inhibidores de ire-1 alfa.
|
|
US8779002B2
(en)
|
2007-10-15 |
2014-07-15 |
Salk Institute For Biological Studies |
Methods for treating a variety of diseases and conditions, and compounds useful therefor
|
|
AU2009274549B2
(en)
*
|
2008-07-23 |
2014-05-01 |
Dana-Farber Cancer Institute, Inc. |
Deacetylase inhibitors and uses thereof
|
|
DE102008053242A1
(de)
|
2008-10-25 |
2010-05-06 |
Saltigo Gmbh |
Heteroaryl-Arylether
|
|
US8927549B2
(en)
*
|
2008-11-21 |
2015-01-06 |
High Point Pharmaceuticals, Llc |
Adamantyl benzamide derivatives
|
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
|
EP2287149A1
(en)
|
2009-08-20 |
2011-02-23 |
Max-Delbrück-Centrum Für Molekulare Medizin |
Enhancers of protein degradation
|
|
DE102010020882A1
(de)
|
2010-05-18 |
2011-11-24 |
Alzchem Trostberg Gmbh |
Semicarbazone zur Härtung von Epoxidharzen
|
|
EP2582666B1
(en)
|
2010-06-16 |
2014-08-13 |
Purdue Pharma L.P. |
Aryl substituted indoles and their use as blockers of sodium channels
|
|
JP2013531687A
(ja)
|
2010-07-16 |
2013-08-08 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
ナトリウムチャネル遮断剤としてのピリジン化合物
|
|
AU2011303597A1
(en)
|
2010-09-17 |
2013-04-11 |
Purdue Pharma L.P. |
Pyridine compounds and the uses thereof
|
|
KR20130095772A
(ko)
|
2010-10-05 |
2013-08-28 |
퍼듀 퍼머 엘피 |
나트륨 채널 차단제로서 퀴나졸린 화합물
|
|
KR101861883B1
(ko)
|
2010-12-06 |
2018-05-28 |
글락소 그룹 리미티드 |
Lp-PLA₂에 의해 매개되는 질환 또는 상태의 치료에 사용하기 위한 피리미디논 화합물
|
|
EP2655330B1
(en)
|
2010-12-22 |
2016-02-10 |
Purdue Pharma LP |
Substituted pyridines as sodium channel blockers
|
|
EP3255041A1
(en)
|
2011-09-02 |
2017-12-13 |
Purdue Pharma L.P. |
Pyrimidines as sodium channel blockers
|
|
WO2013064883A1
(en)
|
2011-10-31 |
2013-05-10 |
Purdue Pharma L.P. |
Heteroaryl compounds as sodium channel blockers
|
|
WO2013064884A1
(en)
|
2011-10-31 |
2013-05-10 |
Purdue Pharma L.P. |
Quaternized amines as sodium channel blockers
|
|
DE102011118501A1
(de)
|
2011-11-15 |
2013-05-16 |
Alzchem Ag |
Alkyl- oder Dialkyl-Semicarbazone als Härter für Epoxidharze
|
|
US9133131B2
(en)
|
2011-11-15 |
2015-09-15 |
Purdue Pharma L.P. |
Pyrimidine diol amides as sodium channel blockers
|
|
WO2013136170A1
(en)
|
2012-03-16 |
2013-09-19 |
Purdue Pharma L.P. |
Substituted pyridines as sodium channel blockers
|
|
EP2872125A4
(en)
|
2012-07-10 |
2016-02-24 |
Dana Farber Cancer Inst Inc |
ANTIPROLIFERATIVE COMPOUNDS AND USES THEREOF
|
|
EP2935257B1
(en)
|
2012-12-20 |
2018-02-07 |
Purdue Pharma LP |
Cyclic sulfonamides as sodium channel blockers
|
|
US9120786B2
(en)
|
2013-03-04 |
2015-09-01 |
Purdue Pharma, L.P. |
Triazine carboxamides as sodium channel blockers
|
|
WO2014135955A1
(en)
|
2013-03-04 |
2014-09-12 |
Purdue Pharma L.P. |
Pyrimidine carboxamides as sodium channel blockers
|
|
CA2939549C
(en)
|
2013-03-15 |
2020-08-18 |
Purdue Pharma L.P. |
Carboxamide derivatives and use thereof
|
|
CA3129741C
(en)
|
2013-05-01 |
2023-09-19 |
Neoculi Pty Ltd |
Compounds and methods of treating infections
|
|
CN105612152A
(zh)
|
2013-08-26 |
2016-05-25 |
普渡制药公司 |
氮杂螺[4.5]癸烷衍生物及其用途
|
|
US9359330B2
(en)
|
2013-08-26 |
2016-06-07 |
Purdue Pharma L.P. |
Substituted piperidines as sodium channel blockers
|
|
US9828348B2
(en)
|
2013-11-08 |
2017-11-28 |
Purdue Pharma L.P. |
Benzimidazole derivatives and use thereof
|
|
US9340504B2
(en)
|
2013-11-21 |
2016-05-17 |
Purdue Pharma L.P. |
Pyridine and piperidine derivatives as novel sodium channel blockers
|
|
US9745287B2
(en)
|
2013-12-20 |
2017-08-29 |
Purdue Pharma L.P. |
Pyrimidines and use thereof
|
|
US9695144B2
(en)
|
2013-12-23 |
2017-07-04 |
Purdue Pharma L.P. |
Dibenzazepine derivatives and use thereof
|
|
JP6337124B2
(ja)
|
2013-12-23 |
2018-06-06 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
インダゾール及びその使用
|
|
EP3089978B1
(en)
|
2013-12-30 |
2018-08-29 |
Purdue Pharma L.P. |
Pyridone-sulfone morphinan analogs as opioid receptor ligands
|
|
JP6526023B2
(ja)
|
2014-01-24 |
2019-06-05 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
ピリジン類及びピリミジン類並びにその使用
|
|
AU2015217185B2
(en)
|
2014-02-12 |
2018-04-05 |
Purdue Pharma L.P. |
Isoquinoline derivatives and use thereof
|
|
US10730866B2
(en)
|
2014-04-07 |
2020-08-04 |
Purdue Pharma L.P. |
Indole derivatives and use thereof
|
|
CA2948144A1
(en)
|
2014-05-06 |
2015-11-12 |
Purdue Pharma L.P. |
Benzomorphan analogs and use thereof
|
|
WO2015192039A1
(en)
|
2014-06-13 |
2015-12-17 |
Purdue Pharma L.P. |
Heterocyclic morphinan derivatives and use thereof
|
|
MA40171A
(fr)
|
2014-06-13 |
2017-04-19 |
Purdue Pharma Lp |
Dérivés d'azamophinan et leur utilisation
|
|
WO2018125716A1
(en)
|
2017-01-02 |
2018-07-05 |
Purdue Pharma L.P. |
Morphinan derivatives and use thereof
|